Article Text

Download PDFPDF
Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Statistics from Altmetric.com

Footnotes

  • Contributors WX and YW wrote the paper. ZZ reviewed and edited the manuscript. All authors have read and approved the content of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles